Interleukin-33, a Target of Parathyroid Hormone and Oncostatin M, Increases Osteoblastic Matrix Mineral Deposition and Inhibits Osteoclast Formation in Vitro
Hasnawati Saleh(Hasanuddin University), J Quinn(The University of Melbourne), Matthew T. Gillespie(Hudson Institute of Medical Research), Ran Gu(Monash University), Jason M. Hodge(Deakin University), Damien G. Eeles(La Trobe University), Sueli Pompolo(St Vincents Institute of Medical Research), Geoffrey C. Nicholson(University of Salford)
Cited by 72
Related Papers
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
|Endocrine Reviews|1999|2.3k
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
|Journal of Clinical Investigation|1999|1.7k
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
|Endocrinology|1999|536
Osteotropic Agents Regulate the Expression of Osteoclast Differentiation Factor and Osteoprotegerin in Osteoblastic Stromal Cells
|Endocrinology|1998|452
Activated T Lymphocytes Support Osteoclast Formation in Vitro
|Biochemical and Biophysical Research Communications|1999|425